Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to 0.87.

  • Adma Biologics' Asset Utilization Ratio fell 13.15% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 13.15%. This contributed to the annual value of 1.04 for FY2024, which is 36.84% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Asset Utilization Ratio is 0.87, which was down 2.28% from 0.89 recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Asset Utilization Ratio peaked at 1.03 during Q2 2024, and registered a low of 0.22 during Q1 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.89 (2023), whereas its average is 0.87.
  • As far as peak fluctuations go, Adma Biologics' Asset Utilization Ratio soared by 139.58% in 2022, and later dropped by 13.50% in 2025.
  • Quarterly analysis of 5 years shows Adma Biologics' Asset Utilization Ratio stood at 0.43 in 2021, then surged by 41.33% to 0.60 in 2022, then surged by 47.56% to 0.89 in 2023, then increased by 9.29% to 0.97 in 2024, then declined by 13.15% to 0.87 in 2025.
  • Its Asset Utilization Ratio was 0.87 in Q3 2025, compared to 0.89 in Q2 2025 and 0.92 in Q1 2025.